Evidence map›Paper›PMID 34094583›Full record

ArticleNew microbes and new infections2021

Molecular survey of aminoglycoside-resistant

P Rashvand, A Peymani, M Mohammadi, A A Karami, R Samimi, S Hajian, D Porasgari, N Habibollah-Pourzereshki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Virulence · 2026
    Review
  2. Article
  3. Resistome, virulome and genomic insights into the silent dissemination ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Eco-Friendly Synthesis ofBioinorganic chemistry and applications · 2026
    Article
  5. Review
  6. Whole-genome sequencing ofMicrobial genomics · 2025
    Article
  7. Article
  8. Genotypic Patterns of Multidrug-ResistantAdvanced biomedical research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

P RashvandStudent Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran.
A PeymaniMedical Microbiology Research Centre, Qazvin University of Medical Sciences, Qazvin, Iran.
M MohammadiStudent Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran.
A A KaramiDepartment of Urology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
R SamimiMedical Microbiology Research Centre, Qazvin University of Medical Sciences, Qazvin, Iran.
S HajianDepartment of Nephrology, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran.
D PorasgariMedical Microbiology Research Centre, Qazvin University of Medical Sciences, Qazvin, Iran.
N Habibollah-PourzereshkiMedical Microbiology Research Centre, Qazvin University of Medical Sciences, Qazvin, Iran.
Qazvin University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aminoglycoside-modifying enzymes (AMEs) and 16S rRNA methylases (16S RMTase) are two main resistance mechanisms against aminoglycosides. This study aimed to evaluate the frequency of AMEs and 16S rRNA methylase genes among aminoglycoside non-susceptible

Indexed as

16S rRNA methylasesAcinetobacter baumanniiaminoglycoside-modifying enzymesrepetitive extragenic palindromic-PCR

Identifiers

PMID34094583
PMCPMC8165567
OpenAlexW3157785480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.